$LNBY
Landbay Inc

2024 Q3 Form 10-Q Financial Statement

#000149315224032173 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $2.059K
YoY Change -35.21%
Cost Of Revenue $1.658K
YoY Change -42.27%
Gross Profit $401.00
YoY Change 31.05%
Gross Profit Margin 19.48%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $8.545K $48.85K
YoY Change 5.56% 190.78%
Operating Profit -$8.144K -$48.85K
YoY Change 4.56% 190.78%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $20.00 $23.00
YoY Change -135.09% 15.0%
Pretax Income -$8.124K
YoY Change 3.49%
Income Tax $105.00
% Of Pretax Income
Net Earnings -$8.229K -$48.83K
YoY Change 4.88% 190.99%
Net Earnings / Revenue -399.66%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 30.00M shares 30.00M shares
Diluted Shares Outstanding 30.00M shares 30.00M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change
Cash & Equivalents $370.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $370.00
YoY Change -96.33%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $370.00
Total Long-Term Assets $0.00 $0.00
Total Assets $370.00
YoY Change -96.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $43.83K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $52.42K $43.83K
YoY Change -55.94% -60.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $52.42K $43.83K
Total Long-Term Liabilities $0.00
Total Liabilities $52.42K $43.83K
YoY Change -55.94% -60.66%
SHAREHOLDERS EQUITY
Retained Earnings -$510.1K -$501.9K
YoY Change 9.81% 9.89%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$52.05K -$43.83K
YoY Change
Total Liabilities & Shareholders Equity $370.00
YoY Change -96.33%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$8.229K -$48.83K
YoY Change 4.88% 190.99%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$50.79K
YoY Change 320.55%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $42.03K
YoY Change 513.8%
NET CHANGE
Cash From Operating Activities -$50.79K
Cash From Investing Activities
Cash From Financing Activities $42.03K
Net Change In Cash -$8.761K
YoY Change 67.51%
FREE CASH FLOW
Cash From Operating Activities -$50.79K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Cash
Cash
usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
usd
CY2024Q2 us-gaap Assets
Assets
usd
CY2024Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
usd
CY2023Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2024Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q2 LNBY Loan Forgiveness By Related Parties
LoanForgivenessByRelatedParties
usd
CY2024Q2 dei Document Type
DocumentType
10-Q
CY2024Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q2 dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
CY2024Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q2 dei Entity File Number
EntityFileNumber
000-56182
CY2024Q2 dei Entity Registrant Name
EntityRegistrantName
LANDBAY INC
CY2024Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2024Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-1260549
CY2024Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
Room 3501
CY2024Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
EFC Building, Yuhang District
CY2024Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Hangzhou City
CY2024Q2 dei Entity Address Country
EntityAddressCountry
CN
CY2024Q2 dei City Area Code
CityAreaCode
+86
CY2024Q2 dei Local Phone Number
LocalPhoneNumber
18621851468
CY2024Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q2 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q2 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30000000 shares
CY2024Q2 us-gaap Loans Payable Current
LoansPayableCurrent
43825 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
43825 usd
CY2024Q2 us-gaap Liabilities
Liabilities
43825 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
428054 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-501879 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-453051 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-43825 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-97392 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8761 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
48851 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16800 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
48851 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
16800 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-48851 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-16800 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
23 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
20 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-48828 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-16780 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30000000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30000000 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-97392 usd
CY2024Q2 LNBY Adjustments To Additional Paid In Capital Loan Forgiveness By Related Parties
AdjustmentsToAdditionalPaidInCapitalLoanForgivenessByRelatedParties
102395 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-48828 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-43825 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-84255 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-84255 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-16780 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-101035 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-101035 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-48828 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-16780 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5100 usd
CY2024Q2 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-1966 usd
CY2023Q2 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-398 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-50794 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12078 usd
CY2024Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
43911 usd
CY2023Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
6848 usd
CY2024Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1878 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
42033 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6848 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8761 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5230 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8761 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8105 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2875 usd
CY2024Q2 LNBY Loan Forgiveness By Related Parties
LoanForgivenessByRelatedParties
102395 usd
CY2024Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zrtpu4e4CqS5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_z2a3J2IA7557">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts and timing of revenues and expenses, the reported amounts and classification of assets and liabilities, and the disclosure of contingent assets and liabilities. These estimates and assumptions are based on the Company’s historical results as well as management’s future expectations. The Company’s actual results may vary from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-48828 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-16780 usd
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
120000 usd
CY2024Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
109057 usd

Files In Submission

Name View Source Status
0001493152-24-032173-index-headers.html Edgar Link pending
0001493152-24-032173-index.html Edgar Link pending
0001493152-24-032173.txt Edgar Link pending
0001493152-24-032173-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
lnby-20240630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lnby-20240630_cal.xml Edgar Link unprocessable
lnby-20240630_def.xml Edgar Link unprocessable
lnby-20240630_lab.xml Edgar Link unprocessable
lnby-20240630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable